These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, Broide DH, Aceves SS. J Allergy Clin Immunol; 2013 Jun 01; 131(6):1576-82. PubMed ID: 23623266 [Abstract] [Full Text] [Related]
14. Pathogenic role of mast cells in experimental eosinophilic esophagitis. Niranjan R, Mavi P, Rayapudi M, Dynda S, Mishra A. Am J Physiol Gastrointest Liver Physiol; 2013 Jun 15; 304(12):G1087-94. PubMed ID: 23599040 [Abstract] [Full Text] [Related]
15. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice. Venturelli N, Lexmond WS, Ohsaki A, Nurko S, Karasuyama H, Fiebiger E, Oyoshi MK. J Allergy Clin Immunol; 2016 Nov 15; 138(5):1367-1380.e5. PubMed ID: 27233150 [Abstract] [Full Text] [Related]
18. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Andreae DA, Hanna MG, Magid MS, Malerba S, Andreae MH, Bagiella E, Chehade M. Am J Gastroenterol; 2016 Aug 31; 111(8):1187-97. PubMed ID: 27325220 [Abstract] [Full Text] [Related]